<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(12)</volume><submitter>Ballantine RD</submitter><pubmed_abstract>The brevicidine and laterocidine family of lipopeptide antibiotics exhibit strong activity against multidrug-resistant Gram-negative bacteria, while showing low propensity to induce resistance. Both peptides feature a branched lipid tail on the N-terminal residue, which for brevicidine is chiral. Here, we report the synthesis and biological evaluation of a library of brevicidine and laterocidine analogues wherein the N-terminal lipid is replaced with linear achiral fatty acids. Optimal lipid chain lengths were determined and new analogues with strong activity against colistin-resistant E. coli produced.</pubmed_abstract><journal>RSC medicinal chemistry</journal><pagination>1640-1643</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9749936</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine.</pubmed_title><pmcid>PMC9749936</pmcid><pubmed_authors>Ballantine RD</pubmed_authors><pubmed_authors>Hoekstra M</pubmed_authors><pubmed_authors>Bann SJ</pubmed_authors><pubmed_authors>Martin NI</pubmed_authors><pubmed_authors>Cochrane SA</pubmed_authors><pubmed_authors>Al Ayed K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine.</name><description>The brevicidine and laterocidine family of lipopeptide antibiotics exhibit strong activity against multidrug-resistant Gram-negative bacteria, while showing low propensity to induce resistance. Both peptides feature a branched lipid tail on the N-terminal residue, which for brevicidine is chiral. Here, we report the synthesis and biological evaluation of a library of brevicidine and laterocidine analogues wherein the N-terminal lipid is replaced with linear achiral fatty acids. Optimal lipid chain lengths were determined and new analogues with strong activity against colistin-resistant E. coli produced.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-18T16:30:32.045Z</modification><creation>2025-04-07T03:44:02.835Z</creation></dates><accession>S-EPMC9749936</accession><cross_references><pubmed>36545437</pubmed><doi>10.1039/d2md00281g</doi></cross_references></HashMap>